Publicaciones Google Scholar de
1980 a
2024
| Título |
Fuente |
Fecha |
| FABP4 Enhances Lipidic and Fibrotic Cardiac Structural and Ca 2+ Dynamic Changes |
Circulation: Arrhythmia and Electrophysiology 17 (9), e012683 , 2024 |
2024 |
| Reply to Benndorff and DiFrancesco: Reliable human HCN4 single-channel recordings using the cell-attached configuration in expression systems |
Proceedings of the National Academy of Sciences 121 (16), e2402992121 , 2024 |
2024 |
| Cardiovascular Therapy in Women with Hypertension or Heart Failure |
Manual of Cardiovascular Disease in Women, 419-443 , 2024 |
2024 |
| Variable Penetrance and Expressivity of a Rare Pore Loss-of-Function Mutation (p. L889V) of Nav1. 5 Channels in Three Spanish Families |
International Journal of Molecular Sciences 25 (9), 4686 , 2024 |
2024 |
| Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effect |
Pharmacological Research, 107077 , 2024 |
2024 |
| Coexistent HCN4 and GATA5 Rare Variants and Atrial Fibrillation in a Large Spanish Family |
Canadian Journal of Cardiology , 2024 |
2024 |
| News in cardiovascular pharmacotherapy from the ACC. 24 Meeting |
European Heart Journal-Cardiovascular Pharmacotherapy, pvae034 , 2024 |
2024 |
| Erratum: Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on … |
Erratum: Facing the challenge of polypharmacy when prescribing for older … , 2023 |
2023 |
| A rare gain of function HCN4 gene mutation is responsible for inappropriate sinus tachycardia in a Spanish family |
medRxiv, 2023.01. 20.23284606 , 2023 |
2023 |
| A gain-of-function HCN4 mutant in the HCN domain is responsible for inappropriate sinus tachycardia in a Spanish family |
Proceedings of the National Academy of Sciences 120 (49), e2305135120 , 2023 |
2023 |
| Sex and gender differences in the treatment of arterial hypertension |
Expert review of clinical pharmacology 16 (4), 329-347 , 2023 |
2023 |
| Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on … |
European Heart Journal-Cardiovascular Pharmacotherapy 8 (4), 406-419 , 2022 |
2022 |
| Cancer chemotherapy-induced sinus bradycardia: a narrative review of a forgotten adverse effect of cardiotoxicity |
Drug Safety 45 (2), 101-126 , 2022 |
2022 |
| Sex-related differences in the pharmacological treatment of heart failure |
Pharmacology & Therapeutics 229, 107891 , 2022 |
2022 |
| A Cantú syndrome mutation produces dual effects on K ATP channels by disrupting ankyrin B regulation |
Journal of General Physiology 155 (1), e202112995 , 2022 |
2022 |
| Tbx5 variants disrupt Nav1. 5 function differently in patients diagnosed with Brugada or Long QT Syndrome |
Cardiovascular research 118 (4), 1046-1060 , 2022 |
2022 |
| Empagliflozin and Dapagliflozin Increase Na + and Inward Rectifier K + Current Densities in Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells … |
Cells 11 (23), 3707 , 2022 |
2022 |
| Hypertrophic cardiomyopathy: an up-to-date snapshot of the clinical drug development pipeline |
Expert Opinion on Investigational Drugs 31 (10), 1027-1052 , 2022 |
2022 |
| Regulation of cardiac ion channels by transcription factors: Looking for new opportunities of druggable targets for the treatment of arrhythmias |
Biochemical Pharmacology 204, 115206 , 2022 |
2022 |
| Empagliflozin and dapagliflozin increase Na current in human cardiomyocytes |
European Heart Journal 43 (Supplement_2), ehac544. 2885 , 2022 |
2022 |
| Los fármacos, los canales iónicos y las arritmias cardiacas: retorno a Ítaca |
Actualidad en farmacología y terapéutica 19 (3), 142-145 , 2021 |
2021 |
| The pharmacotherapeutic management of hyperkalemia in patients with cardiovascular disease |
Expert Opinion on Pharmacotherapy 22 (10), 1319-1341 , 2021 |
2021 |
| Zfhx3 decreases expression of cardiac Nav1. 5 channels and inhibits sodium current |
European Heart Journal 42 (Supplement_1), ehab724. 3209 , 2021 |
2021 |
| Una variante rara en HCN4 produce un fenotipo de hipertrabeculación/no compactación ventricular, dilatación auricular izquierda y bradicardia sinusal |
Revista Española de Cardiología 74 (9), 781-789 , 2021 |
2021 |
| Zfhx3 Transcription Factor Represses the Expression of SCN5A Gene and Decreases Sodium Current Density (I Na ) |
International Journal of Molecular Sciences 22 (23), 13031 , 2021 |
2021 |
| Novel PITX2 homeodomain-contained mutations from ATRIAL fibrillation patients deteriorate calcium homeostasis |
Hearts 2 (2), 251-269 , 2021 |
2021 |
| A rare HCN4 variant with combined sinus bradycardia, left atrial dilatation, and hypertrabeculation/left ventricular noncompaction phenotype |
Revista Española de Cardiología (English Edition) 74 (9), 781-789 , 2021 |
2021 |
| Class III Antiarrhythmic Drugs |
Antiarrhythmic Drugs, 107-180 , 2020 |
2020 |
| Electrofisiología cardíaca |
Fisiología humana , 2020 |
2020 |
| The p.P888L SAP97 polymorphism increases the transient outward current (I to,f ) and abbreviates the action potential duration and the QT interval |
Scientific Reports 10 (1), 10707 , 2020 |
2020 |
| La función de bomba del corazón |
Fisiología humana , 2020 |
2020 |
| Prediction of coronary disease incidence by biomarkers of inflammation, oxidation, and metabolism |
Scientific Reports. 2018 Feb 16; 8 (1): 3191 , 2019 |
2019 |
| Recent advances in the pharmacological treatment of cardiovascular disease |
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 125, 7-8 , 2019 |
2019 |
| New drugs in preclinical and early stage clinical development in the treatment of heart failure |
Expert Opinion on Investigational Drugs 28 (1), 51-71 , 2019 |
2019 |
| La expresividad variable del síndrome de QT largo de una familia española se explica por la heterocigosis digénica en SCN5A y CACNA1C |
Revista Española de Cardiología 72 (4), 324-332 , 2019 |
2019 |
| Probiotic Lactobacillus plantarum IS 10506 supplementation increase SCFA of women with functional constipation |
Iranian Journal of Microbiology 11 (5), 389 , 2019 |
2019 |
| Pharmacotherapy for hypertension in pregnant patients: special considerations |
Expert Opinion on Pharmacotherapy 20 (8), 963-982 , 2019 |
2019 |
| Digenic heterozigosity in SCN5A and CACNA1C explains the variable expressivity of the long QT phenotype in a Spanish family |
Revista Española de Cardiología (English Edition) 72 (4), 324-332 , 2019 |
2019 |
| Brugada syndrome trafficking–defective Nav1. 5 channels can trap cardiac Kir2. 1/2.2 channels |
JCI insight 3 (18) , 2018 |
2018 |
| Reciprocity of cardiac sodium and potassium channels in the control of excitability and arrhythmias |
Cardiac Electrophysiology: From Cell to Bedside: Seventh Edition, 187-197 , 2018 |
2018 |
| A missense mutation in the Tbx5 transcription factor causes long QT syndrome |
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 48, 59-60 , 2018 |
2018 |
| Prediction of coronary disease incidence by biomarkers of inflammation, oxidation, and metabolism |
Scientific reports 8 (1), 3191 , 2018 |
2018 |
| Cardiac Kir2.1 and Na V 1.5 Channels Traffic Together to the Sarcolemma to Control Excitability |
Circulation research 122 (11), 1501-1516 , 2018 |
2018 |
| HCN4 AND GATA5 PREVIOUSLY UNDESCRIBED VARIANTS IN A LARGE KINDRED WITH FAMILIAL ATRIAL FIBRILLATION |
Journal of the American College of Cardiology 71 (11S), A328-A328 , 2018 |
2018 |
| New therapeutic approaches for the treatment of hyperkalemia in patients treated with renin-angiotensin-aldosterone system inhibitors |
Cardiovascular Drugs and Therapy 32, 99-119 , 2018 |
2018 |
| Kir2. 1-Nav1. 5 channel complexes are differently regulated than Kir2. 1 and Nav1. 5 channels alone |
Frontiers in physiology 8, 903 , 2017 |
2017 |
| CELLULAR BIOLOGY OF HUMAN CARDIAC NAV1. 5-KIR2. 1 CHANNEL COMPLEXES |
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 121, 60-60 , 2017 |
2017 |
| Tbx20 controls the expression of the KCNH2 gene and of hERG channels |
Proceedings of the National Academy of Sciences 114 (3), E416-E425 , 2017 |
2017 |
| GLIBENCLAMIDE INHIBITS ATP-SENSITIVE K CURRENTS IN THE CANTU SYNDROME |
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 121, 59-60 , 2017 |
2017 |
| A DLG1 polymorphism shortens the action potential duration and the QT interval |
EUROPEAN HEART JOURNAL 38, 1342-1342 , 2017 |
2017 |
| A MUTATION IN THE TBX5 TRANSCRIPTION FACTOR DECREASES THE HUMAN CARDIAC SODIUM CURRENT AND IS ASSOCIATED WITH THE BRUGADA SYNDROME |
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 121, 61-61 , 2017 |
2017 |
| Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes |
International Journal of Cardiology 233, 1-11 , 2017 |
2017 |
| A mutation in the gene encoding the tbx5 transcription factor is associated with the Brugada Syndrome |
EUROPEAN HEART JOURNAL 38, 1235-1235 , 2017 |
2017 |
| P6281 A DLG1 polymorphism shortens the action potential duration and the QT interval |
European Heart Journal 38 (suppl_1), ehx493. P6281 , 2017 |
2017 |
| P1584 A HCN4 previously undescribed variant in a large kindred with familial atrial fibrillation |
EP Europace 19 (suppl_3), iii335-iii336 , 2017 |
2017 |
| P5836 A mutation in the gene encoding the tbx5 transcription factor is associated with the Brugada Syndrome |
European Heart Journal 38 (suppl_1), ehx493. P5836 , 2017 |
2017 |
| miR-208b upregulation interferes with calcium handling in HL-1 atrial myocytes: Implications in human chronic atrial fibrillation |
Journal of molecular and cellular cardiology 99, 162-173 , 2016 |
2016 |
| Cardiac electrical defects in progeroid mice and Hutchinson–Gilford progeria syndrome patients with nuclear lamina alterations |
Proceedings of the National Academy of Sciences 113 (46), E7250-E7259 , 2016 |
2016 |
| Pitx2c increases in atrial myocytes from chronic atrial fibrillation patients enhancing I Ks and decreasing I Ca,L |
Cardiovascular research 109 (3), 431-441 , 2016 |
2016 |
| ÔØ Å ÒÙ× Ö ÔØ |
|
2016 |
| Cardiac Kir2.1 and Na V 1.5 Channels Associate in a Macromolecular Complex Early in Their Forward Trafficking Pathway |
Circulation 134 (suppl_1), A19332-A19332 , 2016 |
2016 |
| Nav1. 5 N-terminal domain binding to α1-syntrophin increases membrane density of human Kir2. 1, Kir2. 2 and Nav1. 5 channels |
Cardiovascular research 110 (2), 279-290 , 2016 |
2016 |
| A missense mutation in the transcription factor TBX20 gene causes long QT syndrome |
EUROPEAN HEART JOURNAL 36, 1037-1037 , 2015 |
2015 |
| New Antianginal Drugs Still Not Available for Clinical Use |
Pharmacological Treatment of Chronic Stable Angina Pectoris, 189-234 , 2015 |
2015 |
| Cancer chemotherapy and cardiac arrhythmias: a review |
Drug safety 38, 129-152 , 2015 |
2015 |
| Regulation of SCN5A by microRNAs: miR-219 modulates SCN5A transcript expression and the effects of flecainide intoxication in mice |
Heart Rhythm 12 (6), 1333-1342 , 2015 |
2015 |
| The renin–angiotensin system and bone |
Clinical Reviews in Bone and Mineral Metabolism 13, 125-148 , 2015 |
2015 |
| Nav1. 5 N-terminus is responsible for the Nav1. 5 and Kir2. x reciprocal modulation |
EUROPEAN HEART JOURNAL 35, 275-275 , 2014 |
2014 |
| Pitx2 decreases L-type Ca2+ current and increases the slow delayed rectifier K plus current in cardiac cells |
EUROPEAN HEART JOURNAL 35, 954-954 , 2014 |
2014 |
| New drugs for the treatment of hyperkalemia in patients treated with renin-angiotensin-aldosterone system inhibitors—hype or hope? |
Discovery Medicine 18 (100), 249-254 , 2014 |
2014 |
| 279 Pitx2 regulates multiple AF associated GWAS genes |
Cardiovascular Research 103 (suppl_1), S50-S50 , 2014 |
2014 |
| Pharmacologic bases of antiarrhythmic therapy |
Cardiac Electrophysiology: From Cell to Bedside: Sixth Edition, 529-540 , 2014 |
2014 |
| Structural basis of drugs that increase cardiac inward rectifier Kir2. 1 currents |
Cardiovascular research 104 (2), 337-346 , 2014 |
2014 |
| Chronic atrial fibrillation increases microRNA-21 in human atrial myocytes decreasing L-type calcium current |
Circulation: Arrhythmia and Electrophysiology 7 (5), 861-868 , 2014 |
2014 |
| MiR-208a/b decreases cardiac L-type Ca2+ current by targeting CACNA1C and CACNB2 mRNA |
EUROPEAN HEART JOURNAL 35, 451-451 , 2014 |
2014 |
| New Paradigms in Arrhythmias |
Cardiovascular Research 103, S50 , 2014 |
2014 |
| NAV1. 5 N-TERMINUS EXHIBITS A PDZ BINDING DOMAIN AND INCREASES THE KIR2. 1 CHANNEL DENSITY |
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 115, 59-59 , 2014 |
2014 |
| PHARMACOPHORE OF DRUGS THAT INCREASE I-KIR2. 1 |
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 115, 12-13 , 2014 |
2014 |
| PITX2 DECREASES L-TYPE CA (2+) CURRENT AND INCREASES THE SLOW DELAYED RECTIFIER K+ CURRENT IN CARDIAC CELLS |
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 115, 58-59 , 2014 |
2014 |
| Chronic atrial fibrillation up-regulates β1-adrenoceptors affecting repolarizing currents and action potential duration |
Cardiovascular research 97 (2), 379-388 , 2013 |
2013 |
| Functional characterization of a novel frameshift mutation in the C-terminus of the Nav1. 5 channel underlying a Brugada syndrome with variable expression in a Spanish family |
PLoS One 8 (11), e81493 , 2013 |
2013 |
| Human cardiac Kir2. 1, but not Kir2. 3, channel expression is regulated by Nav1. 5 |
European Heart Journal 34 (suppl_1), P5019 , 2013 |
2013 |
| p. D1690N Nav1. 5 rescues p. G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient |
Heart Rhythm 10 (2), 264-272 , 2013 |
2013 |
| Propafenone blocks human cardiac Kir2. x channels by decreasing the negative electrostatic charge in the cytoplasmic pore |
Biochemical pharmacology 86 (2), 267-278 , 2013 |
2013 |
| Función de bomba del corazón: el ciclo cardíaco |
Tresguerres JA, Benitez EA, Cachofeiro MV, Cardinali DP, Gil Loyzaga P … , 2012 |
2012 |
| Functional effects of p. D1690N and p. G1748D Nav1. 5 mutations detected in compound heterozygosity in a patient with Brugada syndrome |
EUROPEAN HEART JOURNAL 33, 944-944 , 2012 |
2012 |
| Drug-induced atrial fibrillation |
Expert opinion on drug safety 11 (4), 615-634 , 2012 |
2012 |
| Lists of Reviewers for 2012 |
Cardiovascular Research, 97 , 2012 |
2012 |
| Drug-induced atrial fibrillation: does it matter? |
Discovery Medicine 14 (78), 295-299 , 2012 |
2012 |
| Functional effects of a missense mutation in HERG associated with type 2 long QT syndrome |
Heart Rhythm 8 (3), 463-470 , 2011 |
2011 |
| Effects of beta-adrenoceptor stimulation on human atrial voltage-dependent K plus currents |
EUROPEAN HEART JOURNAL 32, 942-942 , 2011 |
2011 |
| Chronic (−)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats |
British Journal of Nutrition 106 (9), 1337-1348 , 2011 |
2011 |
| ISSN 1699-3993 e-ISSN 1699-4019 Copyright 2011 Clarivate CCC: 1699-3993 |
Drugs Today 47 (2), 109 , 2011 |
2011 |
| Ranolazine: an antianginal drug with antiarrhythmic properties |
Expert Review of Cardiovascular Therapy 9 (7), 815-827 , 2011 |
2011 |
| Purchase Agreement |
Drugs Today 47 (2), 109 , 2011 |
2011 |
| Dronedarone. |
Drugs of Today (Barcelona, Spain: 1998) 47 (2), 109-133 , 2011 |
2011 |
| New therapeutic targets for the development of positive inotropic agents |
Discovery medicine 12 (66), 381-392 , 2011 |
2011 |
| PITX2 Insufficiency Leads to Atrial Electrical and Structural Remodeling Linked to Arrhythmogenesis |
Circulation: Cardiovascular Genetics 4 (3), 269-279 , 2011 |
2011 |
| Mutations in the cardiac L-type calcium channel associated with inherited sudden cardiac death Syndromes |
Heart Rhythm 7 (11), 1719 , 2010 |
2010 |
| Clinical pharmacology of ranolazine, a novel compound for treating chronic stable angina |
Revista Espanola de Cardiologia Suplementos 10 (SUPPL. 2) , 2010 |
2010 |
| Non Invasive Assessment of Myocardial Fibrosis in Human Atrial Fibrillation |
Circulation 122 (suppl_21), A19214-A19214 , 2010 |
2010 |
| Cardiac electrophysiological effects of nitric oxide |
Cardiovascular research 87 (4), 593-600 , 2010 |
2010 |
| Cinaciguat, a soluble guanylate cyclase activator for the potential treatment of acute heart failure |
Curr Opin Investig Drugs 11 (9), 1039-1047 , 2010 |
2010 |
| Comparative expression of proteins in left and right atrial appendages from patients with mitral valve disease at sinus rhythm and atrial fibrillation |
Journal of cardiovascular electrophysiology 21 (8), 859-868 , 2010 |
2010 |
| Endocannabinoids and cannabinoid analogues block human cardiac Kv4. 3 channels in a receptor-independent manner |
Journal of molecular and cellular cardiology 48 (1), 201-210 , 2010 |
2010 |
| In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and … |
Journal of the American College of Cardiology 55 (21), 2346-2354 , 2010 |
2010 |
| Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death |
Heart rhythm 7 (12), 1872-1882 , 2010 |
2010 |
| New investigational drugs for the management of acute heart failure syndromes |
Current medicinal chemistry 17 (4), 363-390 , 2010 |
2010 |
| Endocannabinoids and cannabinoid analogues block cardiac hKv1. 5 channels in a cannabinoid receptor-independent manner |
Cardiovascular Research 85 (1), 56-67 , 2010 |
2010 |
| Farmacología clínica de la ranolazina, un nuevo fármaco en el tratamiento de la angina crónica estable |
Revista española de cardiología suplementos 10, 41B-54B , 2010 |
2010 |
| Flecainide increases Kir2. 1 currents by interacting with cysteine 311, decreasing the polyamine-induced rectification |
Proceedings of the National Academy of Sciences 107 (35), 15631-15636 , 2010 |
2010 |
| Endocannabinoids and cannabinoid analogues block human cardiac Kv4. 3 channels in a receptor-independent manner |
|
2009 |
| Fisiopatología de la prorrenina y la renina. Cincuenta años en busca de los inhibidores directos de la renina. Sus ventajas y sus limitaciones |
Rev. esp. cardiol. Supl.(Ed. impresa), 24a-40a , 2009 |
2009 |
| Molecular, cellular and pathophysiological mechanisms of human atrial fibrillation |
Nat Clin Pract Cardiovasc Med (CNIC Edition) 6, 15-21 , 2009 |
2009 |
| Nitric Oxide Increases Cardiac I K1 by Nitrosylation of Cysteine 76 of Kir2.1 Channels |
Circulation research 105 (4), 383-392 , 2009 |
2009 |
| Propafenone and Flecainide increase the current through human cardiac Kir2. 1 channels |
EUROPEAN HEART JOURNAL 30, 73-73 , 2009 |
2009 |
| Physiopathology of Prorenin and Renin. Fifty Years in Search of Direct Renin Inhibitors. Their Benefits and Limitations |
REVISTA ESPANOLA DE CARDIOLOGIA, 24A-40A , 2009 |
2009 |
| Futuro del tratamiento farmacológico de las enfermedades cardiovasculares |
Monografías de la Real Academia Nacional de Farmacia , 2009 |
2009 |
| Vagal stimulation and atrial electrical remodeling. |
Revista Espanola de Cardiologia 62 (7), 729-732 , 2009 |
2009 |
| Omecamtiv mecarbil cardiac myosin activator treatment of heart failure |
Drugs of the Future 34 (12) , 2009 |
2009 |
| La fibrilación auricular |
Libro de la salud cardiovascular del hospital clínica san carlos y la … , 2009 |
2009 |
| I Kur /Kv1.5 channel blockers for the treatment of atrial fibrillation |
Expert opinion on investigational drugs 18 (4), 399-416 , 2009 |
2009 |
| Estimulación vagal y remodelado eléctrico auricular |
Revista española de cardiología 62 (7), 729-732 , 2009 |
2009 |
| Investigational positive inotropic agents for acute heart failure |
Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current … , 2009 |
2009 |
| ENDOCANNABINOIDS DIRECTLY BLOCK Kv4. 3 and Kv1. 5 CARDIAC CHANNELS |
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY 30, 171-171 , 2008 |
2008 |
| Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients |
PROTEOMICS–Clinical Applications 2 (9), 1300-1312 , 2008 |
2008 |
| Functional Effects of KCNE3 Mutation and Its Role in the Development of Brugada Syndrome |
Circulation: Arrhythmia and Electrophysiology 1 (3), 209-218 , 2008 |
2008 |
| NITRIC OXIDE INCREASES HUMAN CARDIAC Kir2. 1 CHANNELS AND HYPERPOLARISES THE RESTING MEMBRANE POTENTIAL |
Methods and Findings in Experimental and Clinical Pharmacology 30, 172-172 , 2008 |
2008 |
| Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current ( I to1 ) |
Cardiovascular research 80 (3), 375-384 , 2008 |
2008 |
| Nitric oxide increases human cardiac Kir2. 1 currents |
European Heart Journal 29, 715-716 , 2008 |
2008 |
| Effects of MiRP1 and DPP6 β‐subunits on the blockade induced by flecainide of K V 4.3/KChIP2 channels |
British journal of pharmacology 154 (4), 774-786 , 2008 |
2008 |
| Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy |
Pharmacology & therapeutics 114 (1), 107-126 , 2007 |
2007 |
| Fármacos antiarrítmicos |
Cardiomecum. Eds. Guindo J, Bertomeu V, González-Juanatey JR. Publicaciones … , 2007 |
2007 |
| Effects of atorvastatin and simvastatin on atrial plateau currents |
Journal of molecular and cellular cardiology 42 (5), 931-945 , 2007 |
2007 |
| beta-subunits KChIP2, KCNE2 and DPP6 modulate effects of flecainide on transient outward current I-TO |
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 375, 45-46 , 2007 |
2007 |
| Ivabradina, un bloqueador selectivo de la corriente If. Aspectos farmacológicos y tolerabilidad |
Revista Española de Cardiología Suplementos 7 (4), 32D-45D , 2007 |
2007 |
| Genetically engineered mice as a model for studying cardiac arrhythmias |
Front Biosci 12, 22-38 , 2007 |
2007 |
| Declarative debugging of Maude functional modules |
|
2007 |
| Circulación coronaria |
HUMANA, 563 , 2006 |
2006 |
| Características farmacológicas de los ARA-II.¿ Son todos iguales? |
Revista Española de Cardiología Suplementos 6 (3), 10C-24C , 2006 |
2006 |
| The safety of digoxin as a pharmacological treatment of atrial fibrillation |
Expert Opinion on Drug Safety 5 (3), 453-467 , 2006 |
2006 |
| Circulación capilar |
HUMANA, 535 , 2006 |
2006 |
| Towards a Set Oriented Calculus for Logic Programming |
Programación y Lenguajes, P. Lucio y F. Orejas (editors), CIMNE, 41-50 , 2006 |
2006 |
| Effects of nitric oxide on cardiac Kv4. 3 channels |
EUROPEAN HEART JOURNAL 27, 413-413 , 2006 |
2006 |
| Generalidades del aparato cardiovascular. La célula cardíaca |
HUMANA, 438 , 2006 |
2006 |
| Association of 14-3-3 Proteins to β 1 -Adrenergic Receptors Modulates Kv11.1 K + Channel Activity in Recombinant Systems |
Molecular biology of the cell 17 (11), 4666-4674 , 2006 |
2006 |
| Nitric oxide blocks hKv1. 5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism |
Cardiovascular research 72 (1), 80-89 , 2006 |
2006 |
| Mecanismo de acción de la eplerenona |
Revista Española de Cardiología Suplementos 6 (2), 31B-47B , 2006 |
2006 |
| Farmacología de los ácidos grasos omega-3 |
Revista Española de Cardiología Suplementos 6 (4), 3D-19D , 2006 |
2006 |
| Effects of nitric oxide on cardiac function |
Revista Espanola de Cardiologia Suplementos 6 (A) , 2006 |
2006 |
| Mecánica cardíaca |
HUMANA, 477 , 2006 |
2006 |
| Pharmacology of omega 3 polyinsaturated fatty acids |
Rev Esp Cardiol 6 (Suppl D), 3-19 , 2006 |
2006 |
| Efectos del óxido nítrico sobre la función cardíaca |
Revista Española de Cardiología Suplementos 6 (1), 3A-20A , 2006 |
2006 |
| Effects of nitric oxide on a human atrial potassium channel (hKv1. 5) |
EUROPEAN HEART JOURNAL 26, 453-453 , 2005 |
2005 |
| 14-3-3 Proteins modulate the regulation of HERG channels by beta (1)-adrenoceptor |
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY 39 (1), 169-169 , 2005 |
2005 |
| Angiotensin II, angiotensin II antagonists and spironolactone and their modulation of cardiac repolarization |
Trends in pharmacological sciences 26 (3), 155-161 , 2005 |
2005 |
| Effects of atorvastatin on hKv1. 5 and Kv4. 3 potassium currents |
EUROPEAN HEART JOURNAL 26, 452-452 , 2005 |
2005 |
| Propiedades eléctricas del corazón |
HUMANA, 449 , 2005 |
2005 |
| Pro-arrhythmic actions of angiotensin II |
Trends in Pharmacological Sciences 3 (26), 155-161 , 2005 |
2005 |
| Spironolactone and its main metabolite canrenoic acid block hKv1. 5, Kv4. 3 and Kv7. 1+ minK channels |
British journal of pharmacology 146 (1), 146-161 , 2005 |
2005 |
| Diltiazem blocks hKv1. 5 and Kv4. 3 channels |
BIOPHYSICAL JOURNAL 86 (1), 533A-533A , 2004 |
2004 |
| Fármacos antiarrítmicos |
En: Lorenzo P, Moreno A, Leza JC, Lizasoaín I, Moro MA (eds.). Velázquez … , 2004 |
2004 |
| Spironolactone and canrenoic acid block hKv1. 5, Kv4. 3 and KvLQT1+ minK channels |
EUROPEAN HEART JOURNAL 25, 629-629 , 2004 |
2004 |
| Interaction of angiotensin II with the angiotensin type 2 receptor inhibits the cardiac transient outward potassium current |
Cardiovascular research 62 (1), 86-95 , 2004 |
2004 |
| Effects of fatty acids on HERG channels |
BIOPHYSICAL JOURNAL 86 (1), 279A-279A , 2004 |
2004 |
| Spironolactone and canrenoic acid block hKv1. 5 channels |
BIOPHYSICAL JOURNAL 86 (1), 533A-534A , 2004 |
2004 |
| Pharmacology of cardiac potassium channels |
Cardiovascular research 62 (1), 9-33 , 2004 |
2004 |
| Effects of spironolactone and canrenoic acid on Kv4. 3 and KCNQ1+ KCNE1 channels |
CIRCULATION 110 (17), 100-100 , 2004 |
2004 |
| The Kv4. 2 N-terminal restores fast inactivation and confers KChIP2 modulatory effects on N-terminal-deleted Kv1. 4 channels |
Pflügers Archiv 449, 235-247 , 2004 |
2004 |
| Pharmacological approaches in the treatment of atrial fibrillation |
Current medicinal chemistry 11 (1), 13-28 , 2004 |
2004 |
| Diltiazem inhibits hKv1. 5 and Kv4. 3 currents at therapeutic concentrations |
Cardiovascular research 64 (3), 457-466 , 2004 |
2004 |
| Futuro del tratamiento farmacológico de las enfermedades cardiovasculares |
Bayés de Luna A, López-Sendón J, Attie F, Alegría Esquerra E: Cardiología … , 2003 |
2003 |
| Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization |
Journal of Pharmacology and Experimental Therapeutics 304 (2), 862-873 , 2003 |
2003 |
| Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go–related gene channels |
Circulation 107 (6), 889-895 , 2003 |
2003 |
| Effects of propafenone and its main metabolite, 5-hydroxypropafenone, on HERG channels |
Cardiovascular research 57 (3), 660-669 , 2003 |
2003 |
| Futuro del tratamiento farmacológico de las arritmias cardíacas |
Cardiología Clínica. Eds. Bayés de Luna A, López-Sendón J, Attié F, Alegría … , 2003 |
2003 |
| Farmacología clínica de las estatinas |
Revista española de cardiología. Suplemento 3 (3), 2-13 , 2003 |
2003 |
| New mechanistic targets for the treatment of atrial fibrillation |
Atrial Fibrillation: New Therapeutic Concepts. Eds: Papp JP, Straub M … , 2003 |
2003 |
| Farmacología clínica de los antagonistas de los receptores de la angiotensina II |
Revista española de cardiología. Suplemento 3 (2), 3-14 , 2003 |
2003 |
| Effects of propafenone and 5-hydroxypropafenone on HERG channels. |
BIOPHYSICAL JOURNAL 84 (2), 546A-546A , 2003 |
2003 |
| Effects of flecainide and quinidine on Kv4. 2 currents: voltage dependence and role of S6 valines |
British journal of pharmacology 138 (8), 1475-1484 , 2003 |
2003 |
| Effects of angiotensin II on the transient outward current. |
BIOPHYSICAL JOURNAL 84 (2), 235A-235A , 2003 |
2003 |
| Duality in fractional programming involving locally arcwise connected and related functions |
Instituto Complutense de Análisis Económico. Universidad Complutense de Madrid , 2002 |
2002 |
| Los antagonistas de los receptores de la angiotensina II han cumplido las expectativas |
Monocardio 3, 124-38 , 2002 |
2002 |
| Duality in fractional programming involving locally arcwise connected and related functions |
Documentos de Trabajo (ICAE), 1-20 , 2002 |
2002 |
| Putative binding sites for benzocaine on a human cardiac cloned channel (Kv1. 5) |
Cardiovascular research 56 (1), 104-117 , 2002 |
2002 |
| Comparative effects of bupivacaine, levobupivacaine, and ropivacaine on HERG channels stably expressed in CHO cells |
BIOPHYSICAL JOURNAL 82 (1), 581A-581A , 2002 |
2002 |
| Assembly with the Kvβ1. 3 subunit modulates drug block of hKv1. 5 channels |
Molecular pharmacology 62 (6), 1456-1463 , 2002 |
2002 |
| New antiarrhythmic drugs for atrial flutter and atrial fibrillation: A conceptual breakthrough at last? |
Circulation 105 (3), 276-278 , 2002 |
2002 |
| A comparison of currents carried by HERG, with and without coexpression of MiRP1, and the native rapid delayed rectifier current. Is MiRP1 the missing link? |
The Journal of physiology 540 (1), 15-27 , 2002 |
2002 |
| Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: stereoselective bupivacaine block |
British journal of pharmacology 137 (8), 1269-1279 , 2002 |
2002 |
| Analysis and comparisons of some solution concepts for stochastic programming problems |
Top 10 (1), 101-123 , 2002 |
2002 |
| Nuevos fármacos en el tratamiento de la insuficiencia cardíaca aguda |
Monocardio 4, 155-65 , 2002 |
2002 |
| Effects of external K+ on bupivacaine binding to hKv1. 5 channels |
BIOPHYSICAL JOURNAL 82 (1), 584A-584A , 2002 |
2002 |
| A critical role for S6 valines in the pharmacological properties of transient outward current (Ito) carried by Kv4. 2 subunits |
Circulation 104 (Suppl. II), 217 , 2001 |
2001 |
| Bupivacaine effects on hKv1. 5 channels are dependent on extracellular pH |
British journal of pharmacology 134 (2), 359-369 , 2001 |
2001 |
| Stereoselective effects of the enantiomers of a new local anaesthetic, IQB‐9302, on a human cardiac potassium channel (Kv1. 5) |
British journal of pharmacology 132 (2), 385-392 , 2001 |
2001 |
| Clinical pharmacology of the new antiarrhythmia agents |
Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de … , 2001 |
2001 |
| Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization |
Molecular Pharmacology 59 (4), 825-836 , 2001 |
2001 |
| Efficient solution concepts and their relations in stochastic multiobjective programming |
Journal of Optimization Theory and Applications 110, 53-74 , 2001 |
2001 |
| The Kv beta 1.3 subunit reduces the bupivacaine affinity for hKv1. 5 channels |
BIOPHYSICAL JOURNAL 80 (1), 441A-441A , 2001 |
2001 |
| MOLECULAR AND CELLULAR PHARMACOLOGY-Stereoselective effects of the enantiomers of a new local anaesthetic, IQB-9302, on a human cardiac potassium channel (Kvl. 5) |
British Journal of Pharmacology 132 (2), 385-392 , 2001 |
2001 |
| Localization of the binding site of benzocaine on hKv1. 5 channels |
BIOPHYSICAL JOURNAL 80 (1), 441A-441A , 2001 |
2001 |
| Effects of bupivacaine and IQB-9302, a new local anesthetic, on K+ channels |
BIOPHYSICAL JOURNAL 80 (1), 214A-214A , 2001 |
2001 |
| Effects of bupivacaine and a novel local anesthetic, IQB-9302, on human cardiac K+ channels |
Journal of Pharmacology and Experimental Therapeutics 296 (2), 573-583 , 2001 |
2001 |
| Effects or a new local anesthetic, IQB-9302, and its enantiomers on hKv1. 5 channels. |
BIOPHYSICAL JOURNAL 78 (1), 212A-212A , 2000 |
2000 |
| Losartan and Its Metabolite E3174 Modify Cardiac Delayed Rectifier K + Currents |
Circulation 101 (10), 1199-1205 , 2000 |
2000 |
| Effects of a quaternary bupivacaine derivative on delayed rectifier K + currents |
British journal of pharmacology 130 (2), 391-401 , 2000 |
2000 |
| Effects of eprosartan and candesartan on human cardiac delayed rectifier currents |
BIOPHYSICAL JOURNAL 78 (1), 342A-342A , 2000 |
2000 |
| Effects of a permanently charged bupivacaine analog (RB (+) 1C) on Kv1. 5, Kv4. 2 and Kv2. 1 channels |
BIOPHYSICAL JOURNAL 78 (1), 212A-212A , 2000 |
2000 |
| Effects of rupatadine, a new dual antagonist of histamine and platelet‐activating factor receptors, on human cardiac Kv1. 5 channels |
British journal of pharmacology 128 (5), 1071-1081 , 1999 |
1999 |
| Blockade of cardiac potassium and other channels by antihistamines |
Drug safety 21, 11-18 , 1999 |
1999 |
| Evidences for an external bupivacaine receptor in hKv1. 5 channels |
BIOPHYSICAL JOURNAL 76 (1), A189-A189 , 1999 |
1999 |
| The stochastic bottleneck linear programming problem |
Top 7, 123-143 , 1999 |
1999 |
| Benzocaine enhances and inhibits the K + current through a human cardiac cloned channel (Kv1.5) |
Cardiovascular research 42 (2), 510-520 , 1999 |
1999 |
| Effects of benzocaine on hKv1. 5 channels. |
BIOPHYSICAL JOURNAL 74 (2), A212-A212 , 1998 |
1998 |
| Antiarrhythmic actions of drugs interacting with sodium channels |
Ion Channel Pharmacology, 74-94 , 1998 |
1998 |
| Direct effects of losartan and its active metabolite on a human cardiac cloned potassium channel (Kv1. 5) |
British Journal of Pharmacology-Proceedings Supplement, 114P , 1998 |
1998 |
| Chemical determinants of stereoselective local anesthetics block of hKv1. 5 channels. |
BIOPHYSICAL JOURNAL 74 (2), A211-A211 , 1998 |
1998 |
| A functional logic alternative to monads |
Proc. of Workshop on Component-Based Software Development in Computer Logic … , 1998 |
1998 |
| Effects of propafenone and 5-hydroxy-propafenone on hKv1. 5 channels |
British journal of pharmacology 125 (5), 969 , 1998 |
1998 |
| Farmacología de la insuficiencia cardíaca I. Glucósidos digitálicos y otros inotrópicos |
Flórez J, Armijo JA, Mediavilla A. Farmacología Humana 3, 612-21 , 1998 |
1998 |
| Farmacología de la insuficiencia cardíaca II. Fármacos vasodilatadores, β-bloqueantes y diuréticos |
Flórez J, director. Farmacología Humana. 3ª ed. Barcelona: Masson, 627-36 , 1998 |
1998 |
| Interacciones medicamentosas: bloqueadores B-adrenergicos, diureticos, inhibidores de la enzima de conversion, bloqueantes de los canales de calcio |
Pfizer , 1998 |
1998 |
| Effects of changes m extracellular pH on R (+)-bupivacaine-induced block of hKv1. 5 channels |
British Journal of Pharmacology-Proceedings Supplement, 110P , 1998 |
1998 |
| Structural determinants of potency and stereoselective block of hKv1. 5 channels induced by local anesthetics |
Molecular pharmacology 54 (1), 162-169 , 1998 |
1998 |
| Block of hKv 1.5 channels by R (+)-ropivacaine and R (+)-mepivacaine: Structure-activity relationship |
British journal of pharmacology 122, P88-P88 , 1997 |
1997 |
| Comparative effects of nonsedating histamine H1 receptor antagonists, ebastine and terfenadine, on human Kv1. 5 channels |
European journal of pharmacology 326 (2-3), 257-263 , 1997 |
1997 |
| Fármacos antiarrítmicos |
Masson , 1997 |
1997 |
| Threonine 505 determines stereoselective bupivacaine block of hKv1. 5 channels. |
BIOPHYSICAL JOURNAL 72 (2), TUP10-TUP10 , 1997 |
1997 |
| Pharmacology of nitrates |
Annales de Cardiologie et d'Angeiologie 46 (7), 380-390 , 1997 |
1997 |
| Electrophysiological effects of CI‐980, a tubulin binding agent, on guinea‐pig papillary muscles |
British journal of pharmacology 120 (2), 187-192 , 1997 |
1997 |
| The Stochastic Bottleneck Linear Programming Problem |
Facultad de Ciencias Económicas y Empresariales. Instituto Complutense de … , 1997 |
1997 |
| Molecular determinants of stereoselective bupivacaine block of hKv1. 5 channels |
Circulation Research 81 (6), 1053-1064 , 1997 |
1997 |
| Pharmacological therapy of stable angina |
REVISTA LATINA DE CARDIOLOGIA EUROAMERICANA 18, 174-187 , 1997 |
1997 |
| Effect of descarboethoxyloratadine, the major metabolite of loratadine, on the human cardiac potassium channel Kv1. 5 |
British journal of pharmacology 122 (5), 796-798 , 1997 |
1997 |
| Effects of ropivacaine on a potassium channel (hKv1. 5) cloned from human ventricle |
The Journal of the American Society of Anesthesiologists 86 (3), 718-728 , 1997 |
1997 |
| Dual effects of benzocaine on a human cardiac cloned potassium channel (hKv1. 5) |
BRITISH JOURNAL OF PHARMACOLOGY 122, 87P-87P , 1997 |
1997 |
| Block of human cardiac Kv1. 5 channels by loratadine: voltage-, time-and use-dependent block at concentrations above therapeutic levels |
Cardiovascular research 35 (2), 341-350 , 1997 |
1997 |
| Pharmacology of UR‐8225, a New Potassium Channel Opener |
Cardiovascular drug reviews 14 (3), 256-271 , 1996 |
1996 |
| Molecular determinants for stereoselective bupivacaine binding in hKv1. 5 channels. |
BIOPHYSICAL JOURNAL 70 (2), WP124-WP124 , 1996 |
1996 |
| Mechanisms of block of a human cloned potassium channel by the enantiomers of a new bradycardic agent: S‐16257‐2 and S‐16260‐2 |
British journal of pharmacology 117 (6), 1293-1301 , 1996 |
1996 |
| Comparative effects of a non-sedating histamine H1-receptor antagonist on human Kv1. 5 channels |
British Journal of Pharmacology-Proceedings Supplement, 105P , 1996 |
1996 |
| Effects of Loratadine on a delayed rectifier potassium channel cloned from human heart |
ANALES-REAL ACADEMIA DE FARMACIA 62, 25-60 , 1996 |
1996 |
| Class III antiarrhythmic effects of zatebradine: time-, state-, use-, and voltage-dependent block of hKv1. 5 channels |
Circulation 94 (3), 562-570 , 1996 |
1996 |
| Efecto bloqueante de la loratadina en canales de K+ cardiacos humanos clonados |
Anales de la Real Academia de Farmacia 62 (1), 25-60 , 1996 |
1996 |
| Effects of the two enantiomers, S‐16257‐2 and S‐16260‐2, of a new bradycardic agent on guinea‐pig isolated cardiac preparations |
British journal of pharmacology 115 (5), 787-794 , 1995 |
1995 |
| Propafenone Preferentially Blocks the Rapidly Activating Component of Delayed Rectifier K + Current in Guinea Pig Ventricular Myocytes: Voltage-Independent and … |
Circulation research 76 (2), 223-235 , 1995 |
1995 |
| Stereoselective block of a human cardiac potassium channel (Kv1. 5) by bupivacaine enantiomers |
Biophysical Journal 69 (2), 418-427 , 1995 |
1995 |
| Cardiovascular effects of the novel potassium channel opener UR-8225 |
Journal of cardiovascular pharmacology 26 (2), 295-305 , 1995 |
1995 |
| Electromechanical effects of zatebradine on isolated guinea pig cardiac preparations |
Journal of cardiovascular pharmacology 26 (1), 46-54 , 1995 |
1995 |
| Electrophysiological effects of zatebradine in guinea-pig ventricular muscles |
British Journal of Pharmacology-Proceedings Supplement 114, 253-253 , 1995 |
1995 |
| Fármacos antiarrítmicos |
Ars pharmaceutica 36 (4), 507-526 , 1995 |
1995 |
| EFFECTS OF THE ENANTIOMERS OF A NEW BRADYCARDIAC AGENT ON HKV1. 5 CHANNELS |
BIOPHYSICAL JOURNAL 66 (2), A206-A206 , 1994 |
1994 |
| Stereoselective Bupivacaine Block of the Human Cardiac Delayed Rectifier Kv1. 5 Channel |
BIOPHYSICAL JOURNAL 66 (2), A205-A205 , 1994 |
1994 |
| Class I and III antiarrhythmic actions of prazosin in guinea‐pig papillary muscles |
British journal of pharmacology 111 (3), 717-722 , 1994 |
1994 |
| Imipramine blocks rapidly activating and delays slowly activating K+ current activation in guinea pig ventricular myocytes. |
Circulation research 74 (4), 687-699 , 1994 |
1994 |
| Effects of lisinopril on cardiac contractility and ionic currents |
General Pharmacology: The Vascular System 25 (5), 825-832 , 1994 |
1994 |
| Classification of antiarrhythmic drugs. Present status and clinical relevance for the cardiologists |
REVISTA ESPANOLA DE CARDIOLOGIA 46, 183-183 , 1993 |
1993 |
| Cardiac arrhythmias (III). The classification of anti-arrhythmia drugs in the 90s: a focus for the cardiologist |
Revista espanola de cardiologia 46 (3), 183-194 , 1993 |
1993 |
| ANTIARRITMICOS: CLASIFICACION, MODO DE ACTUACION E INTERES TERAPEUTICO |
ANTIARRITMICOS: CLASIFICACION, MODO DE ACTUACION E INTERES TERAPEUTICO 192 … , 1993 |
1993 |
| Anti-arrhythmia agents: classification, mode of action, and therapeutic usefulness |
Revista Clinica Espanola 192 (4), 189-196 , 1993 |
1993 |
| Effects of (S)-nafenodone on 45Ca2+ fluxes and contractions in rat isolated vascular smooth muscle |
European journal of pharmacology 232 (1), 105-111 , 1993 |
1993 |
| Antiarrhythmics: classification, mechanism of action and therapeutical interest |
REVISTA CLINICA ESPANOLA 192, 189-189 , 1993 |
1993 |
| ARRITMIAS CARDIACAS (III). CLASIFICACION DE LOS FARMACOS ANTIARRITMICOS EN LOS 90: UN ENFOQUE PARA EL CARDIOLOGO |
ARRITMIAS CARDIACAS (III). CLASIFICACION DE LOS FARMACOS ANTIARRITMICOS EN … , 1993 |
1993 |
| Electrophysiological effects of the combination of imipramine and desipramine in guinea pig papillary muscles |
Journal of cardiovascular pharmacology 21 (1), 13-20 , 1993 |
1993 |
| Treatment of left ventricular hypertrophy in hypertensive patients. |
European heart journal 14, 102-106 , 1993 |
1993 |
| EFFECTS OF PROPAFENONE ON IK, S AND IK, R IN GUINEA-PIG VENTRICULAR MYOCYTES |
BIOPHYSICAL JOURNAL 64 (2), A314-A314 , 1993 |
1993 |
| STATE-DEPENDENT INTERACTION OF BUPIVACAINE STEREOISOMERS WITH CARDIAC SODIUM-CHANNELS |
BIOPHYSICAL JOURNAL 64 (2), A90-A90 , 1993 |
1993 |
| Effects of lisinopril on electromechanical properties and membrane currents in guinea-pig cardiac preparations. |
British journal of pharmacology 109 (3), 873 , 1993 |
1993 |
| ELECTROPHYSIOLOGICAL INTERACTIONS BETWEEN DESIPRAMINE AND IMIPRAMINE ON GUINEA-PIG PAPILLARY-MUSCLES |
BRITISH JOURNAL OF PHARMACOLOGY 107, P136-P136 , 1992 |
1992 |
| IMIPRAMINE (IMI) BLOCKS IK, R AND DELAYS IK, S ACTIVATION IN GUINEA-PIG VENTRICULAR MYOCYTES |
FASEB JOURNAL 6 (1), A253-A253 , 1992 |
1992 |
| Effects of lisinopril on contractility and electrophysiological properties in guinea-pig cardiac preparations |
BRITISH JOURNAL OF PHARMACOLOGY 107, P135-P135 , 1992 |
1992 |
| New insights into the pharmacology of sodium channel blockers |
European heart journal 13 (suppl_F), 2-13 , 1992 |
1992 |
| Electrophysiological effects of CRE‐1087 in guinea‐pig ventricular muscles |
British journal of pharmacology 107 (2), 515-520 , 1992 |
1992 |
| Pharmacology of CRE‐1087, A New Antiarrhythmic Drug |
Cardiovascular drug reviews 10 (3), 307-322 , 1992 |
1992 |
| Effects of imipramine on the transient outward current in rabbit atrial single cells |
British journal of pharmacology 106 (2), 464-469 , 1992 |
1992 |
| Fisiología humana |
Madrid , 1992 |
1992 |
| STIMULATION-DEPENDENT FACILITATION OF ICA IS INHIBITED BY IMIPRAMINE IN GUINEA-PIG VENTRICULAR MYOCYTES |
FASEB JOURNAL 6 (1), A400-A400 , 1992 |
1992 |
| Further characterization of the effects of imipramine on plateau membrane currents in guinea-pig ventricular myocytes |
Naunyn-Schmiedeberg's archives of pharmacology 344, 645-652 , 1991 |
1991 |
| Dihydropyridines and vascular diseases. |
Zeitschrift fur Kardiologie 80, 106-111 , 1991 |
1991 |
| Electrophysiological effects of the combination of mexiletine and flecainide in guinea‐pig ventricular fibres |
British journal of pharmacology 103 (2), 1411-1416 , 1991 |
1991 |
| Effects of (S)-nafenodone, a new antidepressant, in isolated guinea-pig atrial and ventricular muscle fibres |
European journal of pharmacology 199 (1), 43-50 , 1991 |
1991 |
| Tonic and frequency-dependent block induced by(S)-nafenodone, a new antidepressant drug, in guinea-pig papillary muscles |
Naunyn-Schmiedeberg s Archives of Pharmacology 343 (6) , 1991 |
1991 |
| Tonic and frequency-dependent block induced by (S)-nafenodone, a new antidepressant drug, in guinea-pig papillary muscles |
Naunyn-Schmiedeberg's archives of pharmacology 343 (6), 638-644 , 1991 |
1991 |
| Cardiovascular effects of the new dihydropyridine derivative elgodipine. |
Arzneimittel-forschung 41 (9), 895-900 , 1991 |
1991 |
| Effects of propafenone on 45Ca movements and contractile responses in vascular smooth muscle. |
British journal of pharmacology 103 (2), 1453 , 1991 |
1991 |
| TONIC AND PHASIC VMAX BLOCK INDUCED BY NAFENODONE IN GUINEA-PIG PAPILLARY-MUSCLES |
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY 418 (6), R164-R164 , 1991 |
1991 |
| Tonic and frequency-dependent Vmax block induced by imipramine in guinea pig ventricular muscle fibers |
Journal of cardiovascular pharmacology 15 (3), 414-420 , 1990 |
1990 |
| Optimization of β-blockers' pharmacology |
Journal of cardiovascular pharmacology 16, S10-S18 , 1990 |
1990 |
| AMIODARONE: NUEVOS CONCEPTOS DE SU ACCION ANTIARRITMICA |
AMIODARONE: NUEVOS CONCEPTOS DE SU ACCION ANTIARRITMICA 7 (1), 42-50 , 1990 |
1990 |
| Un parámetro climático para el pronóstico de poblaciones de Heliothis virescens |
Ciencias de la Agricultura , 1990 |
1990 |
| EFFECTS OF PROPAFENE ON CA-45 MOVEMENTS AND CONTRACTILE RESPONSES IN RAT ISOLATED VASCULAR SMOOTH-MUSCLE |
BRITISH JOURNAL OF PHARMACOLOGY 101, P540-P540 , 1990 |
1990 |
| Effects of platelet activating factor on contractile force and 45Ca fluxes in guinea-pig isolated atria. |
British journal of pharmacology 100 (2), 305 , 1990 |
1990 |
| Amiodarone: new concepts on its anti-arrhythmic effect |
Anales de medicina interna (Madrid, Spain: 1984) 7 (1), 42-50 , 1990 |
1990 |
| EFFECTS OF NAFENODONE ON GUINEA-PIG ATRIAL AND VENTRICULAR MUSCLE-FIBERS |
BRITISH JOURNAL OF PHARMACOLOGY 101, P541-P541 , 1990 |
1990 |
| Electrophysiological effects of E‐3753, a new antiarrhythmic drug, in guinea‐pig ventricular muscle |
British journal of pharmacology 96 (4), 970-976 , 1989 |
1989 |
| Electrophysiologic interactions between mexiletine and propafenone in guinea pig papillary muscles |
Journal of cardiovascular pharmacology 14 (3), 351-357 , 1989 |
1989 |
| Modulated receptor hypothesis: selectivity and interactions of antiarrhythmic drugs |
Physiology 4 (3), 88-90 , 1989 |
1989 |
| Mechanism of action of class I antiarrhythmic agents: Modulated receptor hipothesis |
Revista de Farmacologia Clinica y Experimental 5 (1), 53-60 , 1988 |
1988 |
| Tonic and phasic Vmax block induced by 5-hydroxypropafenone in guinea pig ventricular muscles |
Journal of cardiovascular pharmacology 12 (4), 423-431 , 1988 |
1988 |
| Efectos del método de toma de muestras y del combate químico sobre las poblaciones de Heliothis virescens y de su enemigo natural Diadegma sp. en tabaco, bajo condiciones … |
Ciencias de la Agricultura , 1980 |
1980 |
| Effects of sampling methods and controls on Heliothis virescens populations and its natural enemy Diadegma sp. in tobacco under experimental conditions |
Ciencias de la Agricultura (Cuba) , 1980 |
1980 |
